This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
04/29/16 - 1:48:23 PM ET (BATS BZX Real-time Price)
Div Yield: --
MSLI Day's Range
MSLI 52 Week Range
MSLI Business Summary
Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition of prescription medicines primarily in Canada and Europe.View MSLI
Merus Labs International Inc - MSLI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Merus Labs International Inc as a
Hold with a ratings score of C-.
Report Snippet: We rate MERUS LABS INTERNATIONAL INC (MSLI) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive.